suprefact depot 3-months
sanofi - aventis israel ltd - buserelin acetate - rods for implant - buserelin acetate 9.9 mg - buserelin - buserelin - treatment of advanced hormone dependent prostatic carcinoma. however not after bilateral orchiectomy ( no further reduction of testosterone level by buserelin to be expected).
suprefact 3-month depot implant
pharmaco distribution (pty) ltd - implant - see ingredients - each implant contains buserelin acetate equivalent to buserelin 9,45 mg
suprefact 100 mcg/dose nasal spray solution
sanofi-aventis ireland limited t/a sanofi - buserelin acetate - nasal spray solution - 100 mcg/dose - gonadotropin releasing hormone analogues
suprefact 1 mg/ml solution for injection
sanofi-aventis ireland limited t/a sanofi - buserelin - solution for injection - 1 milligram(s)/millilitre - gonadotropin releasing hormone analogues; buserelin
suprefact nasal spray solution
sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - buserelin - nasal spray, solution - buserelin 100 µg - endocrine therapy